Landiolol Does Not Reduce Organ Failure in Septic Shock Patients With Tachycardia
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Nov. 1, 2023 -- An infusion of landiolol does not reduce organ failure among patients with septic shock with tachycardia, according to a study published online Oct. 25 in the Journal of the American Medical Association to coincide with the annual congress of the European Society of Intensive Care Medicine, held from Oct. 21 to 25 in Milan.
Tony Whitehouse, M.D., from the Queen Elizabeth Hospital in Birmingham, England, and colleagues examined the efficacy and safety of landiolol in a randomized trial involving 126 adults with tachycardia and established septic shock treated for at least 24 hours with continuous norepinephrine in 40 U.K. intensive care units. The patients were randomly assigned to usual care (63 patients) or landiolol infusion (63 patients).
On the advice of the independent data monitoring committee, the trial was stopped prematurely as it was considered unlikely to demonstrate benefit and because of potential harm. The researchers found that the mean Sequential Organ Failure Assessment score was 8.8 and 8.1 in the landiolol and standard care groups, respectively (mean difference, 0.75). At day 28 after randomization, mortality was 37.1 and 25.4 percent in the landiolol and standard care groups, respectively (absolute difference, 11.7 percent). At 90 days after randomization, mortality was 43.5 and 28.6 percent in the landiolol and standard care groups, respectively (absolute difference, 15 percent).
"These results do not support the use of landiolol in the management of patients with tachycardia while receiving norepinephrine undergoing treatment for established septic shock," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Novel Criteria Validated for Pediatric Sepsis, Septic Shock
MONDAY, Jan. 29, 2024 -- The Phoenix Criteria are valid for identifying sepsis and septic shock in children, according to two studies published online Jan. 21 in the Journal of...
Oral Switch Noninferior for Low-Risk S. Aureus Bloodstream Infection
FRIDAY, Jan. 26, 2024 -- For patients with low-risk Staphylococcus aureus (S. aureus) bloodstream infection, early switch to oral antimicrobial therapy is noninferior to...
Limited English Proficiency Not Linked to Sepsis Mortality Overall
FRIDAY, Jan. 5, 2024 -- Limited English proficiency (LEP) is not associated with overall sepsis mortality, but in a subgroup analysis, it was associated with mortality among those...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.